0001179110-19-003597.txt : 20190308
0001179110-19-003597.hdr.sgml : 20190308
20190308152734
ACCESSION NUMBER: 0001179110-19-003597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190306
FILED AS OF DATE: 20190308
DATE AS OF CHANGE: 20190308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DArecca James
CENTRAL INDEX KEY: 0001583903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36867
FILM NUMBER: 19668910
MAIL ADDRESS:
STREET 1: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allergan plc
CENTRAL INDEX KEY: 0001578845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
BUSINESS PHONE: (216) 523-5000
MAIL ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis plc
DATE OF NAME CHANGE: 20130930
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis Ltd
DATE OF NAME CHANGE: 20130607
4
1
edgar.xml
FORM 4 -
X0306
4
2019-03-06
0
0001578845
Allergan plc
AGN
0001583903
DArecca James
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,
COOLOCK, CO.
DUBLIN
L2
D17 E400
IRELAND
0
1
0
0
SVP Chief Accounting Officer
Ordinary Shares, par value $0.0001
2019-03-06
4
A
0
2036
137.51
A
7505
D
The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest twenty-five percent (25%) on March 6, 2020, twenty-five percent (25%) on March 6, 2021, twenty-five percent (25%) on March 6, 2022 and twenty-five percent (25%) on March 6, 2023.
Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person
2019-03-08